Before the market opened Tuesday, Roth Capital analyst Chris Lewis reiterated a Buy rating on Enteromedics (NASDAQ:ETRM) with a $3 price target, which represents …
In a research report published today, Roth Capital analyst Chris Lewis maintained a Buy rating on Enteromedics (NASDAQ:ETRM) with a $3.00 price target, …
In a research report issued today, Roth Capital analyst Chris Lewis maintained a Buy rating on Iradimed Corp (NASDAQ:IRMD) with a price target …
In a research report issued today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Lemaitre Vascular (NASDAQ:LMAT) with a price target …
In a research report issued today, Roth Capital analyst Chris Lewis maintained a Buy rating on Exact Sciences (NASDAQ:EXAS) with a price target of …
In a research report issued today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Iradimed Corp (NASDAQ:IRMD) with a price target …
In a research report issued yesterday, Roth Capital analyst Chris Lewis reiterated a Buy rating on Trinity Biotech (NASDAQ:TRIB) and reduced his price …
In a research report issued today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Uroplasty (NASDAQ:UPI) with a price target of …
In a research report issued today, Roth Capital analyst Chris Lewis reiterated a Buy rating on Align Technology (NASDAQ:ALGN) with a price target …
In a research report issued today, Roth Capital analyst Chris Lewis assigned a Buy rating on Tearlab (NASDAQ:TEAR) and reduced his price target to …
